Esperion Therapeutics Stock Forecast
Volatile ride for Esperion Therapeutics stock price on Tuesday moving between $2.13 and $2.53
(Updated on May 07, 2024)
The Esperion Therapeutics stock price gained 11.79% on the last trading day (Tuesday, 7th May 2024), rising from $2.12 to $2.37. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 18.56% from a day low at $2.13 to a day high of $2.53. The price has risen in 7 of the last 10 days and is up by 13.4% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 39 million more shares were traded than the day before. In total, 46 million shares were bought and sold for approximately $108.26 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.03% during the next 3 months and, with a 90% probability hold a price between $1.45 and $2.59 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ESPR Signals & Forecast
Mostly positive signals in the chart today. The Esperion Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.09 and $2.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 28.80%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Esperion Therapeutics stock
On the downside, the stock finds support just below today's level from accumulated volume at $2.07 and $2.05. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Esperion Therapeutics finds support just below today's level at $2.07. If this is broken, then the next support from accumulated volume will be at $2.05 and $1.91.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.395 between high and low, or 18.56%. For the last week, the stock has had daily average volatility of 9.54%.
Our recommended stop-loss: $2.29 (-3.52%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 14 days ago.)
Trading Expectations (ESPR) For The Upcoming Trading Day Of Wednesday 8th
For the upcoming trading day on Wednesday, 8th we expect Esperion Therapeutics to open at $2.34, and during the day (based on 14 day Average True Range), to move between $2.15 and $2.59, which gives a possible trading interval of +/-$0.216 (+/-9.10%) up or down from last closing price. If Esperion Therapeutics takes out the full calculated possible swing range there will be an estimated 18.21% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.62 (10.55%) than the support at $2.07 (12.66%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Esperion Therapeutics stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 2.750 Buy Candidate Upgraded
Predicted Opening Price for Esperion Therapeutics of Wednesday, May 8, 2024
| Fair opening price May 8, 2024 | Current price |
|---|---|
| $2.34 ( 1.19%) | $2.37 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ESPR
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.74 | 15.49 % | |
| R2 | 2.59 | 9.12 % | ||
| R1 | 2.49 | 5.18 % | ||
| Current price: | 2.37 | |||
| Support | S1 | 2.19 | -7.56 % | |
| S2 | 2.10 | -11.50 % | ||
| S3 | 1.95 | -17.87 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.70 | 13.92 % | |
| R2 | 2.68 | 13.08 % | ||
| R1 | 2.62 | 10.55 % | ||
| Current price | 2.37 | |||
| Support | S1 | 2.07 | -12.66% | |
| S2 | 2.05 | -13.50% | ||
| S3 | 1.91 | -19.41% |
FAQ
Click here for our free guide on how to buy Esperion Therapeutics Stock.
